BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Jane E. Churpek present data on a genomic profiling study of African American women with breast cancer referred for genetic counseling at The University of Chicago during a press conference at the 2013 ASCO Annual Meeting in Chicago.
The study found that about one in five carries an inherited abnormality in at least one of 18 genes associated with breast cancer susceptibility. Such mutations were more prevalent among women with aggressive triple negative breast cancer, early onset disease, and a family history of breast and ovarian cancer. The findings suggest that broader genetic screening may be beneficial for these women and their family members.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
The added value of integrative medicine
Insights into germline genetic screening of breast cancer patients
Addressing the rise of multiple myeloma in Rwanda
Best practice in HRRm testing in patients with metastatic prostate cancer
Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems
Novel therapies and combinations in ovarian cancer
The genomics of cancer in Africa
DNA methylation profile of prostate cancer aggressiveness in Ghana